Company
(symbol)#*

Date filed

Shares/units (M)

Price

Shares out@

Lead, other underwriters

Gross (US$M)

INITIAL OFFERINGS

Advanced Accelerator Applications SA (Saint Genis Pouilly, France)

11/17/14

N/A

N/A

N/A

Citigroup (co-lead); Jefferies (co-lead); Canaccord Genuity; JMP Securities

$100

Asymchem Laboratories Co. (Tianjin; China IPO)

6/11/14

30S

N/A

N/A

N/A

N/A

Beijing Science Sun Pharmaceutical Co. Ltd. (Beijing; China IPO)

6/11/14

30S

N/A

N/A

N/A

N/A

Bellicum Pharmaceuticals Inc. (Houston; BLCM)

11/18/14

N/A

N/A

N/A

Jefferies (co-lead); Citigroup Global Markets (co-lead); Piper Jaffray (co-lead)

$115

CB Pharma Acquisition (Burlington, Mass.; CNLMU)1

10/23/14

4U

$10

5.2

Earlybird Capital (lead)

$40

Chengdu Kanghong Pharmaceutical Group (Chengdu; China IPO)

6/11/14

60S

N/A

N/A

N/A

N/A

Civitas Therapeutics Inc. (Chelsea, Mass.; CVTS)

8/26/14

5S

$14-$16

24.2

J.P. Morgan (co-lead); BofA Merrill Lynch (co-lead); Cowen and Co.; Oppenheimer & Co.

$75

Clarus Therapeutics Inc. (Northbrook, Ill.; CLRS)

5/23/14

N/A

N/A

N/A

Citigroup (co-lead); Credit Suisse (co-lead); Canaccord Genuity; Needham & Co.

$86.25

Eyegate Pharma Inc. (Waltham, Mass.; EYEG)2

7/31/14

1.43S

$6-$8

6.88

Aegis Capital Corp. (lead)

$10

Guangzhou Boji Medical & Biotechnological Co. Ltd. (China IPO)

6/11/14

16.67S

N/A

N/A

N/A

N/A

Histogenics Corp. (Waltham, Mass.; HSGX)3

10/7/14

5.9S

$11

12.76

Cowen and Co. (co-lead); Needham & Co. (co-lead); Canaccord Genuity (co-lead); BTIG

$65

Inotek Pharmaceuticals Corp. (Lexington, Mass.; ITEK)

11/5/14

N/A

N/A

N/A

Cowen and Co. (co-lead); Piper Jaffray (co-lead); Canaccord Genuity; Nomura

$86.25

Juno Therapeutics Inc. (Seattle; JUNO)

11/17/14

N/A

N/A

N/A

Morgan Stanley (co-lead); JP Morgan (co-lead); Goldman, Sachs & Co. (co-lead); Leerink Partners

$150

Kolltan Pharmaceuticals Inc. (New Haven, Conn.; KLTN)

9/12/14

N/A

N/A

N/A

Leerink Partners (co-lead); Stifel Nicolaus & Co. (co-lead); Guggenheim Securities; Janney Montgomery Scott

$86.25

Lumena Pharmaceuticals Inc. (San Diego; LIVR)

4/2/2014

N/A

N/A

N/A

Citigroup (co-lead); Cowen and Co. (co-lead); Leerink Partners (co-lead)

$75

Midatech Pharma Ltd. (Abingdon, UK; AIM)

11/26/14

N/A

N/A

N/A

N/A

£30 ($47)

Neurovive Pharmaceutical Asia Ltd. (Hong Kong; Taiwan Exchange)4

3/19/14

N/A

N/A

N/A

N/A

N/A

Oncore Biopharma Inc. (Doylestown, Pa.)5

11/25/14

N/A

N/A

N/A

N/A

N/A

Revo Biologics Inc. (Framingham, Mass.; RBIO)6

6/25/14

3.6S

$13-$15

18.4

Piper Jaffray (co-lead); Guggenheim Securities (co-lead); Roth Capital Partners; BTIG

$50.4

S1 Biopharma Inc. (New York; SXB)7

10/1/14

1.75S

$12-$14

8.13

MLV & Co. (lead); Northland Securities

$22.75

Silenseed Ltd. (Jerusalem; RNAI)

6/18/14

N/A

N/A

N/A

Aegis Capital Corp. (lead)

$36.4

Sunflower Pharmaceutical Group Co. Ltd. (China IPO)

6/11/14

36.5S

N/A

N/A

N/A

N/A

Syndax Pharmaceuticals Inc. (Waltham, Mass.; SNDX)8

3/27/14

4.3S

$13-$15

12.18

Deutsche Bank (co-lead); Jefferies (co-lead); JMP Securities; Wedbush Pacgrow Life Sciences

$60.2

Tobira Therapeutics Inc. (South San Francisco; TBRA)

10/20/14

N/A

N/A

N/A

Oppenheimer & Co. (lead)

$69

Viking Therapeutics Inc. (San Diego; VKTX)9

7/1/14

5S

$10-$12

15.15

Oppenheimer & Co. (co-lead); Roth Capital Partners (co-lead); MLV & Co.; Craig-Hallum Capital Group; Summer Street Research Partners

$55

Zosano Pharma Inc. (Fremont, Calif.; ZSAN)

6/24/14

6.4S

$10-$12

12.16

Wedbush Pacgrow Life Sciences (lead); Ladenburg Thalmann; Roth Capital

$70.4